[B028] 专利保护药物与专利分类

get
https://connect.zhihuiya.com/synapse/patent/detail
在体验中心中试用

通过专利获取专利保护药物和专利分类

请求参数

此 API 接口支持的参数列表

名称类型示例描述
patent_id
stringf00a5247-0886-4ec4-aeae-572b32fe633a
专利ID,通过药物核心专利搜索接口或药物相关专利接口获取

响应结构

API 响应数据的结构说明

字段名类型示例描述
data
object-
响应数据
apno
stringCN200680056438.5
专利公开(公告)号
drug
arrayPlease check the form:PatentDrugDto
药物
drug_id
stringe82b83b42eba4e5ea3f26f8e06081a5a
药物ID
drug_type
array[ { "display_name": [ { "lang": "EN", "name": "Small molecule drug" }, { "lang": "CN", "name": "小分子化药" } ], "normalized_id": "1151dbc710f64a85923dc05d4a5a0ba9" } ]
药物类型详情
display_name
array[ { "lang": "EN", "name": "Autologous CAR-T" }, { "lang": "CN", "name": "自体CAR-T" } ]
字典名称
lang
stringEN
语言
name
stringRanibizumab (Genentech)
药物、靶点、机构、适应症、国家/地区、字典、作用机制等 名称
normalized_id
string2fbfdb3e92d942c48cbb0adb79f23526
字典ID
display_name
array[ { "lang": "EN", "name": "Ranibizumab (Genentech)" }, { "lang": "CN", "name": "雷珠单抗" } ]
药物名称,引用“CommonName”
title
arrayPlease check the form:TextDto
标题
lang
stringCN
语言
text
stringAntibody and checkpoint inhibitor combination therapy
文本
target
arrayPlease check the form:CommonTarget
靶点
target_id
string1c2067e5ab054a8995f73efcfcf56207
靶点ID
short_name
array[ { "lang": "EN", "name": "VEGF" } ]
靶点简称,引用“CommonName”
display_name
array[ { "lang": "EN", "name": "Vascular endothelial growth factor" }, { "lang": "CN", "name": "血管内皮生长因子" } ]
靶点全称,引用“CommonName”
disease
arrayPlease check the form:CommonDisease
适应症
disease_id
string06a9082fe1ec4c97bea31d888b9cfdce
适应症ID
display_name
array[ { "lang": "EN", "name": "Uveitic Macular Edema" }, { "lang": "CN", "name": "葡萄膜炎黄斑水肿" } ]
适应症名称,引用“CommonName”
core_drug
arrayPlease check the form:PatentDrugDto
专利保护药物
patent_id
stringf00a5247-0886-4ec4-aeae-572b32fe633a
专利ID
patent_tech_type
arrayPlease check the form:CommonDictionary
专利技术类型
core_recommend_drug
arrayPlease check the form:PatentDrugDto
专利推荐药物
cde_drug_patent_types
arrayPlease check the form:PatentTypeDto
CDE专利分类
patent_type
object{ "display_name": [ { "lang": "EN", "name": "New Use" }, { "lang": "CN", "name": "医药用途" } ], "normalized_id": "f6d60f79ffbf3d14b0b62f0821755eeb" }
专利类型
exclusivity_code
stringNPP
橙皮书独占权码
patent_type_drug
array[ { "drug_id": "567c4038545f44fb99efc9ff81d9eba2", "display_name": [ { "lang": "EN", "name": "CNA-3103" } ] } ]
专利保护药物
drug_id
stringe82b83b42eba4e5ea3f26f8e06081a5a
药物ID
display_name
array[ { "lang": "EN", "name": "Ranibizumab (Genentech)" }, { "lang": "CN", "name": "雷珠单抗" } ]
药物名称,引用“CommonName”
fda_drug_patent_types
arrayPlease check the form:PatentTypeDto
FDA专利分类
phs_drug_patent_types
arrayPlease check the form:PatentTypeDto
新药情报库专利分类
status
必填
booleanfalse
状态
error_msg
stringThe request parameter format is incorrect!
错误信息
error_code
必填
integer0
错误代码

成功响应示例

成功调用 API 的响应示例

JSON
{
  "data": {
    "apno": "CN200680056438.5",
    "drug": [
      {
        "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
        "drug_type": [
          {
            "display_name": [
              {
                "lang": "EN",
                "name": "Ranibizumab (Genentech)"
              }
            ],
            "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "title": [
      {
        "lang": "CN",
        "text": "Antibody and checkpoint inhibitor combination therapy"
      }
    ],
    "target": [
      {
        "target_id": "1c2067e5ab054a8995f73efcfcf56207",
        "short_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "disease": [
      {
        "disease_id": "06a9082fe1ec4c97bea31d888b9cfdce",
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "core_drug": [
      {
        "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
        "drug_type": [
          {
            "display_name": [
              {
                "lang": "EN",
                "name": "Ranibizumab (Genentech)"
              }
            ],
            "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "patent_id": "f00a5247-0886-4ec4-aeae-572b32fe633a",
    "patent_tech_type": [
      {
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ],
        "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
      }
    ],
    "core_recommend_drug": [
      {
        "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
        "drug_type": [
          {
            "display_name": [
              {
                "lang": "EN",
                "name": "Ranibizumab (Genentech)"
              }
            ],
            "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
          }
        ],
        "display_name": [
          {
            "lang": "EN",
            "name": "Ranibizumab (Genentech)"
          }
        ]
      }
    ],
    "cde_drug_patent_types": [
      {
        "patent_type": {
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ],
          "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
        },
        "exclusivity_code": "NPP",
        "patent_type_drug": [
          {
            "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
            "display_name": [
              {
                "lang": "EN",
                "name": "Ranibizumab (Genentech)"
              }
            ]
          }
        ]
      }
    ],
    "fda_drug_patent_types": [
      {
        "patent_type": {
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ],
          "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
        },
        "exclusivity_code": "NPP",
        "patent_type_drug": [
          {
            "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
            "display_name": [
              {
                "lang": "EN",
                "name": "Ranibizumab (Genentech)"
              }
            ]
          }
        ]
      }
    ],
    "phs_drug_patent_types": [
      {
        "patent_type": {
          "display_name": [
            {
              "lang": "EN",
              "name": "Ranibizumab (Genentech)"
            }
          ],
          "normalized_id": "2fbfdb3e92d942c48cbb0adb79f23526"
        },
        "exclusivity_code": "NPP",
        "patent_type_drug": [
          {
            "drug_id": "e82b83b42eba4e5ea3f26f8e06081a5a",
            "display_name": [
              {
                "lang": "EN",
                "name": "Ranibizumab (Genentech)"
              }
            ]
          }
        ]
      }
    ]
  },
  "status": true,
  "error_code": 0
}

错误码

此接口可能返回的错误码列表

业务错误码

错误码描述
68300004请求参数异常!
68300005查询Api失败!
68300006解析基本存取错误!
68300007存在错误的请求!
68300008服务中断异常,请稍后再试!
68300010文件不符合上传规范!

平台错误码

错误码描述
67200000API整体限流错误!
67200001API整体限流错误!
67200002当前调用速率过快,超过当前配置限制QPS!
67200003申请token的key和secret传参不正确或者客户端已被禁用!
67200004请求的接口无权限请联系我们的支持人员!
67200005账户余额/调用次数不足!
67200006客户端超过开通有效期!
67200007当前调用超过当天配置使用额度!
67200008请检查query参数中必填的apikey是否传输!
67200009apikey与所传的bearerToken不匹配,请检查是否使用在有效期内的token!
67200012请求不合法!
67200100当前服务器状态正忙,请求响应超时!
67200101当前请求的Api不存在请检查请求Path!

HTTP 状态码

状态码描述
0请求成功
401Unauthorized
403Forbidden
404Not Found

性能指标

此接口的预期性能特征

正常响应时间

5000 ms

最大响应时间

10000 ms